0001214659-19-005092.txt : 20190808 0001214659-19-005092.hdr.sgml : 20190808 20190808142817 ACCESSION NUMBER: 0001214659-19-005092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190806 FILED AS OF DATE: 20190808 DATE AS OF CHANGE: 20190808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brister Mark CENTRAL INDEX KEY: 0001323223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37897 FILM NUMBER: 191008968 MAIL ADDRESS: STREET 1: C/O DEXCOM, INC. STREET 2: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OBALON THERAPEUTICS INC CENTRAL INDEX KEY: 0001427570 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5421 AVENIDA ENCINAS STREET 2: SUITE F CITY: San Diego STATE: CA ZIP: 92008 BUSINESS PHONE: 858-480-2400 MAIL ADDRESS: STREET 1: 5421 AVENIDA ENCINAS STREET 2: SUITE F CITY: San Diego STATE: CA ZIP: 92008 4 1 marketforms-45427.xml PRIMARY DOCUMENT X0306 4 2019-08-06 0001427570 OBALON THERAPEUTICS INC OBLN 0001323223 Brister Mark C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008 false true false false Chief Technology Officer Common Stock 2019-08-06 4 P false 5000 4.00 A 38865 D Warrants (Right to Buy) 4.40 2019-08-06 4 P false 3750 0 A 2019-08-06 2024-08-06 Common Stock 3750 3750 D Reflects price paid to underwriters in Issuer's registered offering. Includes Restricted Shares that are subject to vesting. /s/ Nooshin Hussainy as attorney-in-fact for Mark Brister 2019-08-08